Literature DB >> 18945845

Genotypic antiretroviral resistance testing for human immunodeficiency virus type 1 integrase inhibitors by use of the TruGene sequencing system.

Christian Paar1, Christina Palmetshofer, Karin Flieger, Maria Geit, Rolf Kaiser, Herbert Stekel, Jörg Berg.   

Abstract

A sequencing assay for detection of mutations conferring resistance to human immunodeficiency virus type 1 (HIV-1) integrase inhibitors raltegravir and elvitegravir was developed using the automated TruGene sequencing system. The assay returned clear sequencing results for samples with >or=500 RNA copies/ml for mutation detection and HIV-1 subtyping across a spectrum of HIV-1 subtypes.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18945845      PMCID： PMC2593279          DOI： 10.1128/JCM.01246-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Accuracy of the TRUGENE HIV-1 genotyping kit.

Authors:  Robert M Grant; Daniel R Kuritzkes; Victoria A Johnson; John W Mellors; John L Sullivan; Ronald Swanstrom; Richard T D'Aquila; Mark Van Gorder; Mark Holodniy; Robert M Lloyd; Caroline Reid; Gillian F Morgan; Dean L Winslow
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

Review 2.  Computational methods for the design of effective therapies against drug resistant HIV strains.

Authors:  Niko Beerenwinkel; Tobias Sing; Thomas Lengauer; Jörg Rahnenführer; Kirsten Roomp; Igor Savenkov; Roman Fischer; Daniel Hoffmann; Joachim Selbig; Klaus Korn; Hauke Walter; Thomas Berg; Patrick Braun; Gerd Fätkenheuer; Mark Oette; Jürgen Rockstroh; Bernd Kupfer; Rolf Kaiser; Martin Däumer
Journal:  Bioinformatics       Date:  2005-09-06       Impact factor: 6.937

Review 3.  Integrase inhibitors to treat HIV/AIDS.

Authors:  Yves Pommier; Allison A Johnson; Christophe Marchand
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

4.  Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System.

Authors:  Daniel R Kuritzkes; Robert M Grant; Paul Feorino; Marshal Griswold; Marie Hoover; Russell Young; Stephen Day; Robert M Lloyd; Caroline Reid; Gillian F Morgan; Dean L Winslow
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Entirely automated quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma by using the ultrasensitive COBAS AMPLICOR HIV-1 monitor test and RNA purification on the MagNA pure LC instrument.

Authors:  Gabriele Hölzl; Markus Stöcher; Victoria Leb; Herbert Stekel; Jörg Berg
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

6.  Performance characteristics of human immunodeficiency virus type 1 (HIV-1) genotyping systems in sequence-based analysis of subtypes other than HIV-1 subtype B.

Authors:  Linda L Jagodzinski; John D Cooley; Mark Weber; Nelson L Michael
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

7.  Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods.

Authors:  M Erali; S Page; L G Reimer; D R Hillyard
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

8.  Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

Authors:  Martin S Hirsch; Huldrych F Günthard; Jonathan M Schapiro; Françoise Brun-Vézinet; Bonaventura Clotet; Scott M Hammer; Victoria A Johnson; Daniel R Kuritzkes; John W Mellors; Deenan Pillay; Patrick G Yeni; Donna M Jacobsen; Douglas D Richman
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

9.  Performance of the TruGene human immunodeficiency virus type 1 genotyping kit and OpenGene DNA sequencing system on clinical samples diluted to approximately 100 copies per milliliter.

Authors:  Howard B Gale; Virginia L Kan; Rebecca C Shinol
Journal:  Clin Vaccine Immunol       Date:  2006-02

10.  A web-based genotyping resource for viral sequences.

Authors:  Mikhail Rozanov; Uwe Plikat; Colombe Chappey; Andrey Kochergin; Tatiana Tatusova
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971
View more
  4 in total

1.  Genotypic prediction of human immunodeficiency virus type 1 tropism by use of plasma and peripheral blood mononuclear cells in the routine clinical laboratory.

Authors:  Christian Paar; Maria Geit; Herbert Stekel; Jörg Berg
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

2.  Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?

Authors:  Richard M Gibson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

3.  Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.

Authors:  S Saravanan; M Vidya; P Balakrishnan; P Balakrishanan; N Kumarasamy; Sunil S Solomon; S Solomon; Rami Kantor; David Katzenstein; Bharat Ramratnam; Kenneth H Mayer
Journal:  J Virol Methods       Date:  2009-04-02       Impact factor: 2.014

4.  Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.

Authors:  Richard M Gibson; Ashley M Meyer; Dane Winner; John Archer; Felix Feyertag; Ezequiel Ruiz-Mateos; Manuel Leal; David L Robertson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.